Abstract
This report evaluates the natural history and clinicopathologic variables of patients with pseudomyxoma peritonei (PMP), and reviews the authors' experience with different treatments in the current literature. PMP results from implantation of malignant tumors or peritoneal irritation caused from ruptured benign cysts. This entity is traditionally characterized by the accumulation of mucinous ascites and a relatively long survival period. Diffuse peritoneal spread occurs in most patients with PMP, and distant metastasis is infrequent. Disease progression is difficult to predict because of the spectrum of underlying pathologic processes with varying malignant potential. Debulking surgery, radiation therapy and chemotherapy have all been advocated for optimal patient management.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 26 January 1999 / Accepted in revised form: 1 September 1999
Rights and permissions
About this article
Cite this article
Yilmazlar, T., Özuysal, S. & Oktay, I. Pseudomyxoma peritonei: a case report and current concepts in the literature. Tech Coloproctol 3, 157–160 (1999). https://doi.org/10.1007/s101510050037
Issue Date:
DOI: https://doi.org/10.1007/s101510050037